Tissue Array and Tissue Microarray from US Biomax

More than 1612 types of tissue array or tissue microarray to choose from.

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue array (tissue microarray or so called tissue-chips) contains protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

• FDA998, FDA normal organ tissue microarray of human, a great tool to screen therapeutic antibodies in the pharmaceutical industry to follow FDA guidance ("Appendix C: Sources of Normal Tissue Required for Establishing the Specificity of IHC's", in the "Guidance for Submission of Immunohistochemistry Applications to the FDA", June 3, 1998). We have added 3 more types of organs in our tissue microarray than what the FDA suggests. There are three (3) samples (1 each from 3 different normal individuals) for each of the human organs.
• FDA806, FDA normal organ tissue microarray of human, has two slides, 1.5 mm core size in diameter, containing 90 cases of normal tissues of 30 organs and 54 cases of varieties of cancer types as added value, screening both normal organs and cancer tissue for target tissue specificity studies.
• CO6161, High-density colon cancer array, with stage, grade and normal colon tissue, 322 cases/616 cores High-density colon carcinoma microarray, containing 293 cases of colon adenocarcinoma, 1 squamous cell carcinoma, 11 adjacent normal tissue and 17 normal colon tissue, duplicate cores per case of cancer, single core per case of normal tissue
• LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
• BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
• Series of cancer survey tissue arrays with TNM, clinical stage and pathology grade, up to 2600 cases of breast, liver and lung cancer were built, smaller numbers are ovrian cancer and lymphoma etc.
• Test tissue arrays with two identical 12 core arrays on one slide for testing antibody dilutions and experiment conditions in each cancer type are available.
• Disease spectrum tissue arrays (cancer progression) are available. Please browse our Tissue Microarray page to find out from each cancer type only produced by US Biomax!
• PR955, Prostate adenocarcinoma tissue microarray with matched normal adjacent tissue and metastatic bones, with TNM and Gleason scores. This newly added TMA has duplicated cores per case, some with matched normal adjacent tissue, 4 cases with metastasis. Most of cancer samples even have PSA level.
• FDA902, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides. Here are the unique features of the set of FDA frozen tissue microarrays: Thirty different human adult normal organs meeting FDA Guidelines to speed up antibody validation and study tissue specificity of antibodies in diagnostic and therapeutic applications for FDA approval. Three individual donors per organ types result in satisfaction of FDA Guideline. Save labor and cost through validation of crossing 30 different tissues (90 samples) at once. Obtain expression patterns, intensity and distribution of target markers fast and easy. 1.5 mm core size in diameter can represent whole tissue section for IHC and ISH studies.
• FMC407, Multiple organ cancer frozen tissue array, with normal tissue 40 cases/40 cores This frozen tissue microarray contains 20 types organ carcinoma (1 each of giant cell tumor, clear cell carcinoma, hepatocellular carcinoma and seminoma, 3 squamous cell carcinoma , 10 adenocarcinoma, 3 invasive ductal carcinoma) and 20 normal tissue, is a great tool to study antigens not be detected in paraffin tissue or in situ hybridization where RNA level is very low. We also have other 30 more types of frozen TMAs.

Most viewed tissue microarrays (Hits):

CO723, Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05021 (with Full-Scan image)
FDA998, FDA normal organ tissue array of human, 47 cases/99 cores, replaced by FDA999 (with Full-Scan image)
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954 (with Full-Scan image)
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores (with Full-Scan image)
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replacing BR1503 (with Full-Scan image)
T0014, Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores (with Full-Scan image)
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores (with Full-Scan image)
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores (with Full-Scan image)
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725 (with Full-Scan image)
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores (with Full-Scan image)
PR956, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replacing PR955 (with Full-Scan image)
MC5003, High-density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases/500 cores, replacing MC5002 (with Full-Scan image)
KD2084, Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores (with Full-Scan image)
FDA806, FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies
FDA808-1, Multiple organ normal tissue array, tissue 72 cores, replaced by FDA808a-1 (with Full-Scan image)
BC081120, Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases/110 cores, replacing BC081115 (with Full-Scan image)
BC05002, Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases/80 cores (with Full-Scan image)
UNC241, Universal control tissue array, used for screening of more than 90% routine IHC markers, 12 cases/24 cores (with Full-Scan image)
FDA999, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999a (with Full-Scan image)
BC08013, Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 cores, replaced by BC08014 (with Full-Scan image)

Newly added tissue microarrays in recent month:

2012-01-16 BB01011a, Gastric ulcerative tissue array with normal gastric tissue, 14 cases/24 cores, replacing BB01011
2011-12-28 FDA808a-1, Multiple organ normal tissue array, 72 cases/72 cores, replacing FDA808-1
2011-12-28 FDA808a-2, Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing FDA808-2
2011-12-28 T343, Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores
2011-12-19 PA805a, Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing PA805 (with Full-Scan image)
2011-12-12 BS17016a, Brain glioblastoma tissue array, including pathology grade, 40 cases/80 cores, replacing BS17016
2011-12-12 FDA902b-2, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases/45 cores, slide 2 of 2 tissue arrays, replacing FDA902-2
2011-12-05 BR1005a, Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing BR1005 (with Full-Scan image)
2011-12-05 MC809a, Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing MC809 (with Full-Scan image)
2011-12-05 MS481a, Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases/48 cores, replacing MS481 (with Full-Scan image)
2011-12-05 ST483b, Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing ST483 (with Full-Scan image)
2011-12-01 BS17016, Brain glioma tissue array, 33 cases/63 cores, replaced by BS17016a (with Full-Scan image)
2011-11-28 BL1501, Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores (with Full-Scan image)
2011-11-28 LC10010a, Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases/100 cores, replacing LC10010 (with Full-Scan image)
2011-11-28 PR633, Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases/63 cores, replacing PR8010 (with Full-Scan image)
2011-11-21 BR963a, Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores, replacing BR963 (with Full-Scan image)
2011-11-21 LM482a, Lymphoma tissue array with normal lymph node tissue as control, 48 cases/48 cores, replacing LM482 (with Full-Scan image)
2011-11-21 LM801a, Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases/80 cores, replacing LM801 (with Full-Scan image)
2011-11-21 LY1001a, Diffuse large-B cell lymphoma tissue array, 100 cases/100 cores, replacing LY1001 (with Full-Scan image)
2011-11-21 T175, Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases/24 cores, replacing T172 (with Full-Scan image)